TCL Archive “With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.” July 7, 1995
TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001